Gilead Sciences Inc (GILD)
90.19
+0.43
(+0.48%)
USD |
NASDAQ |
Nov 22, 16:00
90.16
-0.03
(-0.03%)
After-Hours: 20:00
Gilead Sciences Cash from Investing (Quarterly): -710.00M for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -710.00M |
| June 30, 2024 | -307.00M |
| March 31, 2024 | -2.207B |
| December 31, 2023 | -727.00M |
| September 30, 2023 | -229.00M |
| June 30, 2023 | -483.00M |
| March 31, 2023 | -826.00M |
| December 31, 2022 | -375.00M |
| September 30, 2022 | -713.00M |
| June 30, 2022 | -308.00M |
| March 31, 2022 | -1.07B |
| December 31, 2021 | -278.00M |
| September 30, 2021 | -234.00M |
| June 30, 2021 | -577.00M |
| March 31, 2021 | -2.042B |
| December 31, 2020 | -8.977B |
| September 30, 2020 | -271.00M |
| June 30, 2020 | -5.023B |
| March 31, 2020 | -344.00M |
| December 31, 2019 | 431.00M |
| September 30, 2019 | -1.841B |
| June 30, 2019 | -6.163B |
| March 31, 2019 | -244.00M |
| December 31, 2018 | 2.735B |
| September 30, 2018 | 2.025B |
| Date | Value |
|---|---|
| June 30, 2018 | 5.241B |
| March 31, 2018 | 4.354B |
| December 31, 2017 | -10.02B |
| September 30, 2017 | -2.114B |
| June 30, 2017 | -4.246B |
| March 31, 2017 | 307.00M |
| December 31, 2016 | -2.675B |
| September 30, 2016 | -3.917B |
| June 30, 2016 | -3.284B |
| March 31, 2016 | -2.109B |
| December 31, 2015 | -2.438B |
| September 30, 2015 | -4.186B |
| June 30, 2015 | -3.552B |
| March 31, 2015 | -2.299B |
| December 31, 2014 | -405.00M |
| September 30, 2014 | -770.00M |
| June 30, 2014 | -487.00M |
| March 31, 2014 | -161.00M |
| December 31, 2013 | 216.76M |
| September 30, 2013 | -8.032M |
| June 30, 2013 | -55.48M |
| March 31, 2013 | -407.26M |
| December 31, 2012 | 50.12M |
| September 30, 2012 | -518.04M |
| June 30, 2012 | -634.96M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-8.977B
Minimum
Dec 2020
431.00M
Maximum
Dec 2019
-1.264B
Average
-530.00M
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -4.005B |
| Merck & Co Inc | -3.845B |
| Pfizer Inc | -2.057B |
| Amgen Inc | -210.00M |
| Vertex Pharmaceuticals Inc | -348.00M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 4.309B |
| Cash from Financing (Quarterly) | -1.379B |
| Free Cash Flow | 9.431B |
| Free Cash Flow Per Share (Quarterly) | 3.324 |
| Free Cash Flow to Equity (Quarterly) | 4.269B |
| Free Cash Flow to Firm (Quarterly) | 4.412B |
| Free Cash Flow Yield | 8.35% |